CXCL8 and lung cancer: Collectively, our findings indicate the miR-182/IL-8/STAT3 cascade as a novel regulatory axis in controlling osteoclast differentiation and osteolytic lesion development in metastatic niches, providing new mechanistic insights into lung cancer bone metastasis and potential therapeutic targets for the treatment of lung cancer bone metastasis.